Skip to content
Triangle logo TriangleGet started
← Full study record

NCT00087438 · OUTCOME

Rate of Disseminated Recurrence at 2 Years

Stereotactic Body Radiation Therapy in Treating Patients With Inoperable Stage I or Stage II Non-Small Cell Lung Cancer · Source last updated 2019-01-16

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

Measure
NUMBER
Unit
percentage of participants
Interval / dispersion
95% Confidence Interval
Time frame
From the start of treatment to 2 years

What was measured

Disseminated recurrence is defined as uninvolved lobe failures and failures beyond the lungs and regional lymph nodes. Time to disseminated recurrence is defined as time from start of treatment to the the date of disseminated recurrence, last known follow-up (censored), or death without disseminated recurrence (competing risk). Rates are estimated using the cumulative incidence method.

Analysis population: Eligible patients

Groups in this outcome

Stereotactic Body Radiation Therapy (SBRT)

20 Gy per fraction for 3 fractions over 1.5-2 weeks, for a total of 60 Gy

Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.

Analysis denominator · Participants

GroupSource count
Stereotactic Body Radiation Therapy (SBRT)55

Reported measurements

Source class 1
Values in percentage of participants · Interval/dispersion: 95% Confidence Interval
GroupValueSpreadLowerUpperComment
Stereotactic Body Radiation Therapy (SBRT)11.1Not reported5.123.0Not reported
Complete source fields
classes
  1. categories
    1. measurements
      1. group Id
        OG000
        lower Limit
        5.1
        upper Limit
        23.0
        value
        11.1
denoms
  1. counts
    1. group Id
      OG000
      value
      55
    units
    Participants
description
Disseminated recurrence is defined as uninvolved lobe failures and failures beyond the lungs and regional lymph nodes. Time to disseminated recurrence is defined as time from start of treatment to the the date of disseminated recurrence, last known follow-up (censored), or death without disseminated recurrence (competing risk). Rates are estimated using the cumulative incidence method.
dispersion Type
95% Confidence Interval
groups
  1. description
    20 Gy per fraction for 3 fractions over 1.5-2 weeks, for a total of 60 Gy
    id
    OG000
    title
    Stereotactic Body Radiation Therapy (SBRT)
param Type
NUMBER
population Description
Eligible patients
reporting Status
POSTED
time Frame
From the start of treatment to 2 years
title
Rate of Disseminated Recurrence at 2 Years
type
SECONDARY
unit Of Measure
percentage of participants

Download exact source JSON → · Snapshot ctgov-results-191f4516d4760045304b24a0

Preserved source evidence · Not medical advice